A metaproteomics-based meta study of samples from patients with inflammatory bowel disease identifies potential markers for diagnosis and therapy monitoring
Maximilian Wolf, Luca Knipper, Kay Schallert, Ann-Cathrin Groba, Patrick Hellwig, Corinna Bang, Philipp Rausch, André Franke, Dirk Benndorf, Konrad Aden, Alexander Sczyrba, Robert Heyer
This study identifies potential biomarkers for IBD diagnosis and monitoring through metaproteomics meta-analysis of over 600 samples.
bioRxiv · Nov 6, 2025 · PreprintBioinformatics